|
MXPA05012547A
(es)
*
|
2003-05-21 |
2006-05-25 |
Prosidion Ltd |
Inhibidores de amida de acido pirrolopiridina-2-carboxilico de fosforilasa de glucogeno.
|
|
US7405210B2
(en)
|
2003-05-21 |
2008-07-29 |
Osi Pharmaceuticals, Inc. |
Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
|
|
GB0314967D0
(en)
*
|
2003-06-26 |
2003-07-30 |
Hoffmann La Roche |
Piperazine derivatives
|
|
AR046132A1
(es)
*
|
2003-10-24 |
2005-11-23 |
Solvay Pharm Gmbh |
Composicin farmaceutica que contiene al menos un compuesto con actividad de receptor de cb1, o un profarmaco , tautomero o sal del mismo, como componente activo adecuado para el tratamiento y/o profilaxis de enfermedades relacionadas con el receptor cb1 en pacientes juveniles y/o para el tratamiento
|
|
WO2005039579A1
(en)
*
|
2003-10-24 |
2005-05-06 |
Solvay Pharmaceuticals Gmbh |
Combination treatment of obesity involving selective cb1-antagonists and lipase inhibitors
|
|
US8685924B2
(en)
|
2004-08-25 |
2014-04-01 |
Takeda Pharmaceutical Company Limited |
Preventives/remedies for stress urinary incontinence and method of screening the same
|
|
RU2007119315A
(ru)
|
2004-10-25 |
2008-11-27 |
Зольвай Фармасьютиклз Гмбх (De) |
Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний
|
|
KR100895758B1
(ko)
*
|
2005-05-03 |
2009-04-30 |
에프. 호프만-라 로슈 아게 |
5-ｈｔ2 리간드로서 테트라사이클릭 아자피라지노인돌린
|
|
WO2006125179A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Xenon Pharmaceuticals Inc. |
Tricyclic compounds and their uses as therapeutic agents
|
|
ES2351940T3
(es)
*
|
2005-11-18 |
2011-02-14 |
F. Hoffmann-La Roche Ag |
Derivados de azaindol-2-carboxamida.
|
|
US7579351B2
(en)
*
|
2005-12-09 |
2009-08-25 |
Hoffmann-La Roche Inc. |
Tricyclic amide derivatives
|
|
AU2006326067A1
(en)
|
2005-12-16 |
2007-06-21 |
F. Hoffmann-La Roche Ag |
Pyrrolo [2 , 3-b] pyridine derivatives as H3 receptor modulators
|
|
EP2018863B9
(en)
|
2006-05-16 |
2015-02-18 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
|
AU2007283113A1
(en)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
|
|
EP2789338A3
(en)
|
2007-11-15 |
2015-01-14 |
Takeda Pharmaceutical Company Limited |
Condensed pyridine derivate and use thereof
|
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
KR20120060207A
(ko)
|
2009-08-26 |
2012-06-11 |
사노피 |
신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
|
|
US20120253036A1
(en)
|
2009-12-11 |
2012-10-04 |
Yukinori Nagakura |
Agent for treating fibromyalgia
|
|
FR2960876B1
(fr)
*
|
2010-06-03 |
2012-07-27 |
Sanofi Aventis |
Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
|
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683703B1
(de)
|
2011-03-08 |
2015-05-27 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8809325B2
(en)
|
2011-03-08 |
2014-08-19 |
Sanofi |
Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
|
|
MY175254A
(en)
*
|
2012-04-26 |
2020-06-17 |
G1 Therapeutics Inc |
Synthesis of lactams
|
|
AU2013301577B2
(en)
*
|
2012-08-06 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
US10836764B2
(en)
*
|
2016-08-19 |
2020-11-17 |
Arena Pharmaceuticals, Inc. |
5-HT2C receptor agonists and compositions and methods of use
|
|
US20210052600A1
(en)
|
2017-12-27 |
2021-02-25 |
Takeda Pharmaceutical Company Limited |
Therapeutic agents for stress urinary incontinence and incotinence of feces
|